查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946994

2026年全球息肉切片檢查市場報告

Polyp Biopsy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，息肉切片檢查市場經歷了顯著成長，預計將從2025年的13.9億美元成長到2026年的15億美元，複合年成長率為8.5%。過去幾年成長要素包括消化器官系統癌症和子宮頸癌發病率的上升、內視鏡技術的進步、篩檢計畫的擴展、人們對早期診斷益處的認知不斷提高以及專科診所的增加。

預計未來幾年息肉切片檢查市場將維持強勁成長，2030年市場規模將達到20.6億美元，複合年成長率（CAGR）為8.2%。預測期內的成長要素包括人工智慧輔助切片檢查手術、微創技術、醫院和診斷檢查室的廣泛應用、與影像和雲端平台的整合以及新型切片檢查工具的開發。預測期內的主要趨勢包括大腸鏡切片檢查、陰道鏡引導下切片檢查、食道胃十二指腸鏡切片檢查、喉鏡切片檢查和內視鏡黏膜切除術（EMR）。

大腸直腸癌發生率的不斷上升預計將顯著推動息肉切片檢查市場的發展。大腸直腸癌是一種發生於大腸或直腸的惡性腫瘤，由結腸內壁上皮細胞異常且不受控制的增生所引起。這種癌症以其侵襲周圍組織和轉移至身體其他部位的能力而聞名。大腸直腸癌病例的增加主要歸因於常見的飲食習慣，例如攝取大量加工食品和膳食纖維攝取量低。這些習慣會導致慢性炎症，破壞腸道菌叢平衡，並促進癌前病變的形成，最終發展為癌症。息肉切片檢查在應對這一趨勢中發揮關鍵作用，它能夠早期發現異常病變並進行組織學檢查，從而實現及時治療並降低疾病進展的風險。例如，總部位於美國的非營利組織美國癌症協會估計，到2025年，美國將新增107,320例結直腸癌病例和46,950例直腸癌病例，導致約52,900人死亡。因此，大腸直腸癌發生率的上升正在推動對多息肉切片檢查手術的需求。

息肉切片檢查市場的主要企業正在投資人工智慧 (AI) 輔助檢測系統等先進技術，以提高結腸息肉識別的準確性，並實現對有癌症風險病變的早期檢測。 AI 輔助檢測系統是醫療設備，可即時分析影像數據，檢測異常情況並向醫務人員提供視覺警報，從而在無需治療的情況下為臨床決策提供支援。例如，2024 年 9 月，總部位於美國的醫療技術公司 Odin Medical Ltd. 與Olympus Corporation合作，推出了基於雲端的人工智慧內視鏡平台「CADDIE」。 CADDIE 系統可即時分析大腸鏡檢查影像，識別可能存在大腸息肉的區域，從而幫助臨床醫生在檢查過程中做出更明智的決策。臨床評估表明，該系統在不增加檢查時間或風險的情況下提高了腺瘤檢出率，證明了其在支持早期診斷和改善患者照護方面的有效性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球息肉切片檢查市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 生物技術、基因組學和精準醫學
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 大腸鏡切片檢查
    • 陰道鏡引導下切片檢查
    • 食道胃十二指腸切片檢查
    • 喉鏡切片檢查
    • 內視鏡黏膜切除術（EMR）

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷檢查室
  • 專科診所
  • 門診治療中心
  • 研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球息肉切片檢查市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球息肉切片檢查市場規模、對比及成長率分析
  • 全球息肉切片檢查市場表現：規模與成長，2020-2025年
  • 全球息肉切片檢查市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 大腸鏡檢查、陰道鏡引導下切片檢查、食道胃十二指腸鏡檢查
  • 透過技術
  • 內視鏡黏膜切除術（EMR）、內視鏡黏膜下剝離術（ESD）、常規切片檢查
  • 透過使用
  • 結腸癌、消化系統疾病及其他適應症
  • 最終用戶
  • 醫院、專科診所
  • 按類型細分：大腸鏡檢查
  • 診斷性大腸鏡檢查、治療性大腸鏡檢查
  • 按類型細分：陰道鏡引導下切片檢查
  • 子宮頸、切片檢查和切片檢查切片檢查
  • 依類型細分：食道胃十二指腸鏡檢查
  • 診斷性食道胃十二指腸鏡檢查，治療性食道胃十二指腸鏡檢查

第10章 區域與國家分析

  • 全球息肉切片檢查市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球息肉切片檢查市場：按國家/地區、績效和預測分類，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 息肉切片檢查市場：競爭格局與市場佔有率，2024 年
  • 息肉切片檢查市場：公司估值矩陣
  • 息肉切片檢查市場：公司概況
    • Johnson & Johnson（Ethicon）
    • Medtronic plc
    • Medline Industries LP
    • FUJIFILM Holdings Corporation
    • Stryker Corporation

第37章：其他領先和創新企業

  • Becton Dickinson and Company（BD）, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments（Pvt）Ltd., Innovia Medical

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年息肉切片檢查市場：提供新機會的國家
  • 2030年息肉切片檢查市場：新興細分市場機會
  • 息肉切片檢查市場展望（2030 年）：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MPBIO06_G26Q1

A polyp biopsy is a medical procedure in which a healthcare professional removes a small tissue sample from an abnormal growth, or polyp, on the lining of an organ or body cavity. The sample is examined under a microscope to assess cellular characteristics, detect disease, and support accurate diagnosis and treatment planning. This procedure helps determine the nature of polyps, distinguish between benign and malignant conditions, and provide critical information for guiding clinical management or surveillance strategies.

The primary types of polyp biopsy are colonoscopy, colposcopy-directed biopsy, esophagogastroduodenoscopy, and laryngoscopy. Colonoscopy with polyp biopsy involves inserting a flexible camera (colonoscope) into the colon to visualize the intestinal lining and remove tissue samples for diagnostic evaluation. Techniques include endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and conventional biopsy. These procedures are distributed through online channels, retail pharmacies, and other outlets, and are applied in areas such as colorectal cancer and gastrointestinal disorders. End-users include hospitals, diagnostic laboratories, and specialty clinics.

Tariffs have increased the cost of imported biopsy instruments, endoscopic devices, and consumables, affecting hospitals and diagnostic labs in North America and Europe. Segments such as colonoscopy and EMR are most impacted. Positive effects include encouraging domestic manufacturing and technological innovations in cost-effective biopsy instruments.

The polyp biopsy market research report is one of a series of new reports from The Business Research Company that provides polyp biopsy market statistics, including polyp biopsy industry global market size, regional shares, competitors with a polyp biopsy market share, detailed polyp biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the polyp biopsy industry. This polyp biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The polyp biopsy market size has grown strongly in recent years. It will grow from $1.39 billion in 2025 to $1.5 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising prevalence of gastrointestinal and cervical cancers, improvements in endoscopic technologies, increasing screening programs, awareness of early diagnosis benefits, growth of specialty clinics.

The polyp biopsy market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to AI-assisted biopsy procedures, minimally invasive techniques, expansion of hospital and diagnostic laboratory adoption, integration with imaging and cloud platforms, development of novel biopsy tools. Major trends in the forecast period include colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, endoscopic mucosal resection (emr).

The growing prevalence of colorectal cancer is expected to contribute significantly to the expansion of the polyp biopsy market. Colorectal cancer is a malignant condition that develops in the colon or rectum, originating from abnormal and uncontrolled growth of epithelial cells lining the large intestine. This form of cancer is known for its ability to invade nearby tissues and spread to other parts of the body. The increase in colorectal cancer cases is largely attributed to common dietary habits that are high in processed foods and low in fiber. These habits can cause chronic inflammation, disrupt gut microbiota, and encourage the formation of precancerous growths that may eventually become cancerous. Polyp biopsy plays a critical role in addressing this trend by facilitating early detection and histological examination of abnormal lesions, thereby enabling timely treatment and reducing the risk of disease progression. For example, in 2025, the American Cancer Society, a nonprofit organization based in the United States, estimated that there would be 107,320 new cases of colon cancer and 46,950 new cases of rectal cancer in the country, with approximately 52,900 deaths expected as a result. As such, the rising incidence of colorectal cancer is fueling demand for polyp biopsy procedures.

Key companies in the polyp biopsy market are investing in advanced technologies such as artificial intelligence-assisted detection systems to improve the identification of colorectal polyps and enable earlier recognition of potentially cancerous lesions. An artificial intelligence-assisted detection system is a medical tool that evaluates imaging data in real time to detect abnormalities and generate visual alerts for healthcare providers, assisting them in making informed clinical decisions without delivering therapeutic treatments. For example, in September 2024, Odin Medical Ltd., a medical technology firm based in the United States and affiliated with Olympus Corporation, introduced CADDIE, a cloud-based artificial intelligence endoscopy platform. The CADDIE system analyzes colonoscopy footage in real time, identifying areas that may contain colorectal polyps and allowing clinicians to make better decisions during the examination. Clinical evaluations showed that the system improves the rate of adenoma detection without increasing the time or risk involved in the procedure, demonstrating its effectiveness in supporting early diagnosis and improving patient care.

In October 2024, Caldera Medical, a medical device manufacturer based in the United States, acquired UVision360, Inc. for an undisclosed amount. Through this acquisition, Caldera Medical gains access to UVision360's advanced hysteroscopy technology, including the LUMINELLE Bx system, which enhances the company's offerings in minimally invasive diagnostic and treatment options for uterine conditions such as polyps, fibroids, and other intrauterine abnormalities. UVision360 is a company based in the United States that develops hysteroscopy and cystoscopy systems, including the LUMINELLE platform.

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyp biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the polyp biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The polyp biopsy market consists of revenues earned by entities by providing services such as endoscopic ultrasound (EUS), capsule endoscopy, double-balloon enteroscopy, single-balloon enteroscopy, push enteroscopy, transnasal endoscopy, and transanal endoscopic microsurgery (TEM). The market value includes the value of related goods sold by the service provider or included within the service offering. The polyp biopsy market also includes sales of hot biopsy forceps, cold biopsy forceps, endoscopic snares, polypectomy snares, cytology brushes, biopsy needles (fine-needle aspiration needles, core biopsy needles), and endoscopic ultrasound needles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polyp Biopsy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses polyp biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polyp biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polyp biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Colonoscopy; Colposcopy-Directed Biopsy; Esophagogastroduodenoscopy
  • 2) By Technique: Endoscopic Mucosal Resection (EMR); Endoscopic Submucosal Dissection (ESD); Conventional Biopsy
  • 3) By Application: Colorectal Cancer; Gastrointestinal Disorders; Other Applications
  • 4) By End-User: Hospitals; Specialty Clinics
  • Subsegments:
  • 1) By Colonoscopy: Diagnostic Colonoscopy; Therapeutic Colonoscopy
  • 2) By Colposcopy-Directed Biopsy: Cervical Biopsy; Vaginal Biopsy; Vulvar Biopsy
  • 3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy; Therapeutic Esophagogastroduodenoscopy
  • Companies Mentioned: Johnson & Johnson (Ethicon); Medtronic plc; Medline Industries LP; FUJIFILM Holdings Corporation; Stryker Corporation; Becton Dickinson and Company (BD); Boston Scientific Corporation; B. Braun Melsungen AG; Olympus Corporation; STERIS plc; Hologic Inc.; CooperSurgical Inc.; KARL STORZ SE & Co. KG; Cook Medical; ConMed Corporation; Ambu A/S; Richard Wolf GmbH; INRAD; Acheron Instruments (Pvt) Ltd.; Innovia Medical
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Polyp Biopsy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Polyp Biopsy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Polyp Biopsy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Polyp Biopsy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Colonoscopy Biopsy
    • 4.2.2 Colposcopy-Directed Biopsy
    • 4.2.3 Esophagogastroduodenoscopy Biopsy
    • 4.2.4 Laryngoscopy Biopsy
    • 4.2.5 Endoscopic Mucosal Resection (Emr)

5. Polyp Biopsy Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Specialty Clinics
  • 5.4 Ambulatory Care Centers
  • 5.5 Research Institutes

6. Polyp Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Polyp Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Polyp Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Polyp Biopsy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Polyp Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Polyp Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Polyp Biopsy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Polyp Biopsy Market Segmentation

  • 9.1. Global Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy
  • 9.2. Global Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy
  • 9.3. Global Polyp Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Colorectal Cancer, Gastrointestinal Disorders, Other Applications
  • 9.4. Global Polyp Biopsy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialty Clinics
  • 9.5. Global Polyp Biopsy Market, Sub-Segmentation Of Colonoscopy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Colonoscopy, Therapeutic Colonoscopy
  • 9.6. Global Polyp Biopsy Market, Sub-Segmentation Of Colposcopy-Directed Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy
  • 9.7. Global Polyp Biopsy Market, Sub-Segmentation Of Esophagogastroduodenoscopy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy

10. Polyp Biopsy Market Regional And Country Analysis

  • 10.1. Global Polyp Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Polyp Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Polyp Biopsy Market

  • 11.1. Asia-Pacific Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Polyp Biopsy Market

  • 12.1. China Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Polyp Biopsy Market

  • 13.1. India Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Polyp Biopsy Market

  • 14.1. Japan Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Polyp Biopsy Market

  • 15.1. Australia Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Polyp Biopsy Market

  • 16.1. Indonesia Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Polyp Biopsy Market

  • 17.1. South Korea Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Polyp Biopsy Market

  • 18.1. Taiwan Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Polyp Biopsy Market

  • 19.1. South East Asia Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Polyp Biopsy Market

  • 20.1. Western Europe Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Polyp Biopsy Market

  • 21.1. UK Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Polyp Biopsy Market

  • 22.1. Germany Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Polyp Biopsy Market

  • 23.1. France Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Polyp Biopsy Market

  • 24.1. Italy Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Polyp Biopsy Market

  • 25.1. Spain Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Polyp Biopsy Market

  • 26.1. Eastern Europe Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Polyp Biopsy Market

  • 27.1. Russia Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Polyp Biopsy Market

  • 28.1. North America Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Polyp Biopsy Market

  • 29.1. USA Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Polyp Biopsy Market

  • 30.1. Canada Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Polyp Biopsy Market

  • 31.1. South America Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Polyp Biopsy Market

  • 32.1. Brazil Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Polyp Biopsy Market

  • 33.1. Middle East Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Polyp Biopsy Market

  • 34.1. Africa Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Polyp Biopsy Market Regulatory and Investment Landscape

36. Polyp Biopsy Market Competitive Landscape And Company Profiles

  • 36.1. Polyp Biopsy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Polyp Biopsy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Polyp Biopsy Market Company Profiles
    • 36.3.1. Johnson & Johnson (Ethicon) Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medline Industries LP Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Polyp Biopsy Market Other Major And Innovative Companies

  • Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

38. Global Polyp Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Polyp Biopsy Market

40. Polyp Biopsy Market High Potential Countries, Segments and Strategies

  • 40.1 Polyp Biopsy Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Polyp Biopsy Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Polyp Biopsy Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer